NCT05426720Recruiting
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage in a Chinese Cohort: Protocol for a Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 22 Jun 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung function, and chest CT findings, which will aid in the development of prognostic and therapeutic strategies for PTLD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 8 Jun 2022
- Start date
- 1 Jan 2022
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Peking University Third Hospital
- Diseases
- Tuberculosis
- NCT number
- NCT05426720
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Jan 2022 to the primary completion date, 31 Dec 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients infected with multidrug-resistant TB;
- patients with malignant neoplasms (e.g., lung cancer) or severe cardiovascular and cerebrovascular diseases;
Other
- patients with positive sputum smear or TB culture results;
- human immunodeficiency virus-positive patients;
- non-compliant patients who were unable to complete the lung function tests;
- patients without lung parenchymal destruction (such as tuberculous pleurisy). -
Who the study is looking for
- Male patients aged 25-60 years newly diagnosed with active pulmonary TB.
Age in the registry: 25 years to 60 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Geriatric Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| Peking University Third Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.